3MNG
 
 | | wild type human PrxV with DTT bound as a competitive inhibitor | | Descriptor: | (4S,5S)-1,2-DITHIANE-4,5-DIOL, BROMIDE ION, GLYCEROL, ... | | Authors: | Hall, A, Karplus, P.A. | | Deposit date: | 2010-04-21 | | Release date: | 2010-08-04 | | Last modified: | 2023-09-06 | | Method: | X-RAY DIFFRACTION (1.45 Å) | | Cite: | Structural Evidence that Peroxiredoxin Catalytic Power Is Based on Transition-State Stabilization.
J.Mol.Biol., 402, 2010
|
|
4MMM
 | | Human Pdrx5 complex with a ligand BP7 | | Descriptor: | 1,1'-BIPHENYL-3,4-DIOL, Peroxiredoxin-5, mitochondrial | | Authors: | Guichou, J.F. | | Deposit date: | 2013-09-09 | | Release date: | 2014-07-30 | | Last modified: | 2024-03-20 | | Method: | X-RAY DIFFRACTION (1.47 Å) | | Cite: | Comparing Binding Modes of Analogous Fragments Using NMR in Fragment-Based Drug Design: Application to PRDX5
Plos One, 9, 2014
|
|
1HD2
 | | Human peroxiredoxin 5 | | Descriptor: | BENZOIC ACID, BROMIDE ION, PEROXIREDOXIN 5 RESIDUES 54-214 | | Authors: | Declercq, J.P, Evrard, C. | | Deposit date: | 2000-11-06 | | Release date: | 2001-08-28 | | Last modified: | 2024-05-08 | | Method: | X-RAY DIFFRACTION (1.5 Å) | | Cite: | Crystal Structure of Human Peroxiredoxin 5, a Novel Type of Mammalian Peroxiredoxin at 1.5 A Resolution.
J.Mol.Biol., 311, 2001
|
|
1URM
 | | HUMAN PEROXIREDOXIN 5, C47S MUTANT | | Descriptor: | BENZOIC ACID, CHLORIDE ION, PEROXIREDOXIN 5 | | Authors: | Declercq, J.P, Evrard, C. | | Deposit date: | 2003-10-31 | | Release date: | 2004-09-29 | | Last modified: | 2023-12-13 | | Method: | X-RAY DIFFRACTION (1.7 Å) | | Cite: | Crystal Structure of the C47S Mutant of Human Peroxiredoxin 5
J. Chem. Cryst., 34, 2004
|
|
2VL3
 | | Oxidized and reduced forms of human peroxiredoxin 5 | | Descriptor: | PEROXIREDOXIN-5 | | Authors: | Smeets, A, Declercq, J.P. | | Deposit date: | 2008-01-08 | | Release date: | 2008-08-26 | | Last modified: | 2023-12-13 | | Method: | X-RAY DIFFRACTION (1.83 Å) | | Cite: | The Crystal Structures of Oxidized Forms of Human Peroxiredoxin 5 with an Intramolecular Disulfide Bond Confirm the Proposed Enzymatic Mechanism for Atypical 2-Cys Peroxiredoxins.
Arch.Biochem.Biophys., 477, 2008
|
|
2VL2
 | | Oxidized and reduced forms of human peroxiredoxin 5 | | Descriptor: | BENZOIC ACID, PEROXIREDOXIN-5 | | Authors: | Smeets, A, Declercq, J.P. | | Deposit date: | 2008-01-08 | | Release date: | 2008-08-26 | | Last modified: | 2023-12-13 | | Method: | X-RAY DIFFRACTION (1.925 Å) | | Cite: | The Crystal Structures of Oxidized Forms of Human Peroxiredoxin 5 with an Intramolecular Disulfide Bond Confirm the Proposed Enzymatic Mechanism for Atypical 2-Cys Peroxiredoxins.
Arch.Biochem.Biophys., 477, 2008
|
|
1H4O
 | | Monoclinic form of human peroxiredoxin 5 | | Descriptor: | BENZOIC ACID, PEROXIREDOXIN 5 | | Authors: | Declercq, J.P, Evrard, C. | | Deposit date: | 2001-05-11 | | Release date: | 2001-10-23 | | Last modified: | 2024-05-08 | | Method: | X-RAY DIFFRACTION (1.95 Å) | | Cite: | Crystal Structure of Human Peroxiredoxin 5, a Novel Type of Mammalian Peroxiredoxin at 1.5 A Resolution
J.Mol.Biol., 311, 2001
|
|
4K7O
 | | HUMAN PEROXIREDOXIN 5 with a fragment | | Descriptor: | 4-tert-butylbenzene-1,2-diol, DIMETHYL SULFOXIDE, Peroxiredoxin-5, ... | | Authors: | Guichou, J.F. | | Deposit date: | 2013-04-17 | | Release date: | 2014-04-23 | | Last modified: | 2024-03-20 | | Method: | X-RAY DIFFRACTION (1.98 Å) | | Cite: | Comparing Binding Modes of Analogous Fragments Using NMR in Fragment-Based Drug Design: Application to PRDX5
Plos One, 9, 2014
|
|
1OC3
 | | HUMAN PEROXIREDOXIN 5 | | Descriptor: | BENZOIC ACID, PEROXIREDOXIN 5 | | Authors: | Evrard, C, Declercq, J.-P. | | Deposit date: | 2003-02-05 | | Release date: | 2004-02-10 | | Last modified: | 2023-12-13 | | Method: | X-RAY DIFFRACTION (2 Å) | | Cite: | Crystal Structure of a Dimeric Oxidized Form of Human Peroxiredoxin 5
J.Mol.Biol., 337, 2004
|
|
4K7I
 | | HUMAN PEROXIREDOXIN 5 with a fragment | | Descriptor: | CATECHOL, DIMETHYL SULFOXIDE, Peroxiredoxin-5, ... | | Authors: | Guichou, J.F. | | Deposit date: | 2013-04-17 | | Release date: | 2014-04-23 | | Last modified: | 2023-11-08 | | Method: | X-RAY DIFFRACTION (2.25 Å) | | Cite: | Comparing Binding Modes of Analogous Fragments Using NMR in Fragment-Based Drug Design: Application to PRDX5
Plos One, 9, 2014
|
|
4K7N
 | | HUMAN PEROXIREDOXIN 5 with a fragment | | Descriptor: | 4-METHYLCATECHOL, Peroxiredoxin-5, mitochondrial | | Authors: | Guichou, J.F. | | Deposit date: | 2013-04-17 | | Release date: | 2014-04-23 | | Last modified: | 2023-11-08 | | Method: | X-RAY DIFFRACTION (2.3 Å) | | Cite: | Comparing Binding Modes of Analogous Fragments Using NMR in Fragment-Based Drug Design: Application to PRDX5
Plos One, 9, 2014
|
|
2VL9
 | | Oxidized form of human peroxiredoxin 5 | | Descriptor: | PEROXIREDOXIN-5 | | Authors: | Smeets, A, Declercq, J.P. | | Deposit date: | 2008-01-11 | | Release date: | 2008-08-26 | | Last modified: | 2023-12-13 | | Method: | X-RAY DIFFRACTION (2.7 Å) | | Cite: | The Crystal Structures of Oxidized Forms of Human Peroxiredoxin 5 with an Intramolecular Disulfide Bond Confirm the Proposed Enzymatic Mechanism for Atypical 2-Cys Peroxiredoxins.
Arch.Biochem.Biophys., 477, 2008
|
|
